Home / MissionIR Articles

MissionIR Articles

  • Viggle (VGGL) Presents at Rodman & Renshaw Conference

    Viggle, Inc. (NASDAQ:VGGL) is an entertainment marketing and rewards platform whose app rewards its more than 9.0 million registered users for watching TV shows and discovering new music. Members can access the Viggle store via…

  • Vical (VICL) Presents at Rodman & Renshaw Conference

    Vical, Inc. (NASDAQ:VICL) applies its patented DNA delivery technologies and other therapeutic approaches to develop biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases. Headquartered in San Diego, California, Vical is…

  • Verastem (VSTM) Presents at Rodman & Renshaw Conference

    Verastem, Inc. (NASDAQ:VSTM) is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation. The company’s current product line includes: FAK, PI3K/mTOR and Wnt. Verastem’s proprietary research has…

  • VBI Vaccines (VBIV) Presents at Rodman & Renshaw Conference

    VBI Vaccines, Inc. (NASDAQ:VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine. The company has initiated…

  • Uranium Energy (UEC) Presents at Rodman & Renshaw Conference

    Uranium Energy Corp. (NYSE: UEC) is a U.S.-based uranium mining and exploration company with a  fully-licensed Hobson processing plant as the central point of all of its projects in South Texas, including the Palangana in-situ…

  • Ur-Energy (URG) Presents at Rodman & Renshaw Conference

    Ur-Energy, Inc. (NYSE: URG) is a uranium mining company operating the Lost Creek in-situ recovery uranium facility in south-central Wyoming. The Lost Creek processing facility has a two million pounds per year nameplate design capacity.…

  • UQM Technologies (UQM) Presents at Rodman & Renshaw Conference

    UQM Technologies Inc. (NYSE: UQM) develops and manufactures power-dense, high-efficiency electric motors, generators, power electronic controllers and fuel cell compressors for the commercial truck, bus, automotive, marine, military and industrial markets. A major emphasis for…

  • uniQure N.V (QURE) Presents at Rodman & Renshaw Conference

    uniQure N.V. (NASDAQ:QURE) participates in the field of gene therapy and has developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. The company is developing a…

  • US Physical Therapy (USPH) Presents at Rodman & Renshaw Conference

    US Physical Therapy, Inc. (NYSE: USPH) operates 503 clinics in 42 states to provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries, and rehabilitation of injured…

  • TRACON Pharmaceuticals (TCON) Presents at Rodman & Renshaw Conference

    TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) develops targeted therapies for cancer, wet AMD and fibrotic diseases. The company’s current pipeline includes two clinical stage product candidates: TRC105, an anti-endoglin antibody that is being developed for the treatment…

  • Top Image Systems (TISA) Presents at Rodman & Renshaw Conference

    Top Image Systems™ Ltd. (NASDAQ:TISA) provides enterprise solutions for capturing and validating structured and unstructured content entering organizations from various sources and managing content-driven business processes. Whether originating from mobile, electronic, paper or other sources,…

  • Tonix Pharmaceuticals Holding (TNXP) Presents at Rodman & Renshaw Conference

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is focused on the invention and development of novel pharmaceutical products for medical conditions that it believes have broad societal impact, and that are not well served by currently available…

  • Titan Pharmaceuticals (TTNP) Presents at Rodman & Renshaw Conference

    Titan Pharmaceuticals Inc. (OTCQB: TTNP) is a specialty pharmaceutical company developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company’s lead product candidate, Probuphine®, is a novel and long-acting formulation of buprenorphine…

  • Threshold Pharmaceuticals (THLD) Presents at Rodman & Renshaw Conference

    Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in the microenvironments of most solid tumors as well as the…

  • TG Therapeutics (TGTX) Presents at Rodman & Renshaw Conference

    TG Therapeutics, Inc. (NASDAQ:TGTX) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Currently, the company is developing two therapies targeting hematological malignancies: TG-1101…

  • Tecogen (TGEN) Presents at Rodman & Renshaw Conference

    Tecogen Inc. (NASDAQ: TGEN) manufactures, installs and maintains high-efficiency, ultra-clean combined heat and power products – including natural gas engine-drive cogeneration, air conditioning systems and water heaters for residential, commercial and industrial use. For over…

  • TapImmune (TPIV) Presents at Rodman & Renshaw Conference

    TapImmune Inc. (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics comprise one or more naturally…

  • Stevia First (STVF) Presents at Rodman & Renshaw Conference

    Stevia First Corp. (OTCQB: STVF) is an agricultural biotechnology company enabling the production of dramatically healthier food and nutrition products. The company has developed and is commercializing a novel bioprocessing technique that has the potential…

  • Stemline Therapeutics (STML) Presents at Rodman & Renshaw Conference

    Stemline Therapeutics, Inc. (NASDAQ: STML) is a clinical stage biopharmaceutical company developing novel oncology therapeutics that primarily target cancer stem cells and tumor bulk. The company’s pipeline currently includes two clinical stage product candidates, SL-401…

  • StemCells (STEM) Presents at Rodman & Renshaw Conference

    StemCells, Inc. (NASDAQ: STEM) is currently engaged in the clinical development of its innovative HuCNS-SC® platform technology as a potential treatment for both neurological and retinal disorders. The company’s top-line data from its phase I/II…

  • Stellar Biotechnologies (SBOTF) Presents at Rodman & Renshaw Conference

    Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is the leading manufacturer of sustainable keyhole limpet hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. Through a recently executed strategic collaboration, the company has…

  • SteadyMed (STDY) Presents at Rodman & Renshaw Conference

    SteadyMed Ltd. (NASDAQ: STDY) is a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parental delivery needs. The company’s lead drug product candidate, Trevyent®,…

  • Spectrum Pharmaceuticals (SPPI) Presents at Rodman & Renshaw Conference

    Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is a leading biotechnology company focused on acquiring, developing and commercializing drug products. The company currently markets five hematology/oncology drugs, and it expects an FDA decision on another hematology drug…

  • Sorrento Therapeutics (SRNE) Presents at Rodman & Renshaw Conference

    Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is a clinical-stage biopharmaceutical company developing new treatments for cancer, as well as associated pain, inflammation and immune diseases. The company recently licensed multiple late-stage biosimilar and biobetter antibodies for…

  • Solar3D (SLTD) Presents at Rodman & Renshaw Conference

    Solar3D, Inc. (NASDAQ: SLTD) is a leading provider of solar power solutions focused on the design, installation and management of solar power systems for commercial, agricultural and residential customers. Through its wholly-owned subsidiaries, the company…

  • Social Reality (SCRI) Presents at Rodman & Renshaw Conference

    Social Reality, Inc. (OTCQB: SCRI) is an internet advertising company delivering a complete set of advertising and marketing tools and services powered by real-time automation. The company’s proprietary technology connects the social and digital spheres…

  • Smith Micro Software (SMSI) Presents at Rodman & Renshaw Conference

    Smith Micro Software, Inc. (NASDAQ: SMSI) is a provider of software designed to simplify and enhance the mobile experience. As the leader in wireless connectivity, the company’s applications ensure the best quality of experience for…

  • SITO Mobile (SITO) Presents at Rodman & Renshaw Conference

    SITO Mobile Ltd. (NASDAQ: SITO) provides a mobile engagement platform that enables brands to increase awareness, loyalty and sales. Through its location-based advertising services, the company helps clients drive foot traffic into stores and improve…

  • Signal Genetics (SGNL) Presents at Rodman & Renshaw Conference

    Signal Genetics, Inc. (NASDAQ: SGNL) is a commercial-stage molecular design company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company’s lead…

  • Second Sight Medical Products (EYES) Presents at Rodman & Renshaw Conference

    Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets innovative implantable visual prosthetics that enable blind individuals to achieve greater independence. The company’s lead product is the Argus® II Retinal Prosthesis System, which…

  • Safeguard Scientifics (SFE) Presents at Rodman & Renshaw Conference

    Safeguard Scientifics, Inc. (NYSE: SFE) has a distinguished track record of fostering innovation and building market leaders. For six decades, the company has been providing growth capital and operational support to entrepreneurs across an evolving…

  • Rosetta Genomics (ROSG) Presents at Rodman & Renshaw Conference

    Rosetta Genomics Ltd. (NASDAQ: ROSG) develops and commercializes a broad range of microRNA-based and other high-value molecular diagnostics. The company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of…

  • Rock Creek Pharmaceuticals (RCPI) Presents at Rodman & Renshaw Conference

    Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI) is a clinical-stage drug development company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for chronic inflammatory disease and neurologic disorders.…

  • Rexahn Pharmaceuticals (RNN) Presents at Rodman & Renshaw Conference

    Rexahn Pharmaceuticals, Inc. (NYSE: RNN) is a clinical-stage biopharmaceutical company dedicated to the development of novel, best-in-class therapeutics for the treatment of cancer. The company’s product candidates work by targeting and neutralizing specific proteins believed…

  • RestorGenex (RESX) Presents at Rodman & Renshaw Conference

    RestorGenex Corporation (OTCQB: RESX) is a specialty biopharmaceutical company focused on the development of a portfolio of first-in-class therapeutic products to treat diseases across the oncologic, ophthalmologic and dermatologic space. The company’s lead product is…

  • RegeneRx Biopharmaceuticals (RGRX) Presents at Rodman & Renshaw Conference

    RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) is a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration. The company currently has three drug…

  • Reed’s (REED) Presents at Rodman & Renshaw Conference

    Reed’s, Inc. (NYSE: REED) produces the top-selling natural sodas in the natural foods industry and is sold in more than 15,000 natural and mainstream supermarkets nationwide. Additionally, the company’s products are sold through specialty gourmet…

  • RedHill Biopharma (RDHL) Presents at Rodman & Renshaw Conference

    RedHill Biopharma Ltd. (NASDAQ: RDHL) is an emerging Israeli biopharmaceutical company primarily focused on the development of late clinical-stage small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers. The company’s…

  • RealNetworks (RNWK) Presents at Rodman & Renshaw Conference

    RealNetworks, Inc. (NASDAQ: RNWK) creates innovative applications and services that make it easy for consumers to connect with and enjoy digital media on the devices and platforms they choose to use. The company invented the…

  • Rare Element Resources (REE) Presents at Rodman & Renshaw Conference

    Rare Element Resources Ltd. (NYSE: REE) is a strategic materials company focused on delivering rare earth products for technology and defense applications by advancing its Bear Lodge project in northeast Wyoming. Bear Lodge is a…